WallStreetZenWallStreetZen

NASDAQ: IRWD
Ironwood Pharmaceuticals Inc Stock Ownership - Who owns Ironwood Pharmaceuticals?

Insider buying vs selling

Have Ironwood Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jon R. DuaneDirector2024-03-066,920$8.70
$60.20kBuy
Sravan Kumar EmanySVP Chief Financial Officer2024-03-0410,684$9.38
$100.22kBuy
Ronald SilverPrincipal Accounting Officer2024-02-127,908$15.24
$120.52kSell
Andrew DavisSVP Chief Business Officer2024-02-129,846$15.24
$150.05kSell
Minardo JohnChief Legal Officer2024-02-1247,380$15.24
$722.07kSell
Thomas A. McCourtChief Executive Officer2024-02-12177,164$15.24
$2.70MSell
Michael ShetzlineCMOSVPHead-ResDrug2024-02-1238,618$15.24
$588.54kSell
Sravan Kumar EmanySVP Chief Financial Officer2024-02-0841,332$14.90
$615.85kSell
Marla L. KesslerDirector2023-12-149,926$11.19
$111.07kSell
Andrew DavisSVP Chief Business Officer2023-11-203,287$9.69
$31.85kSell

1 of 2

IRWD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IRWD insiders and whales buy or sell their stock.

IRWD Shareholders

What type of owners hold Ironwood Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc16.60%25,980,308$210.44MInstitution
Alexander J. Denner10.55%16,511,939$133.75MInsider
Sarissa Capital Management LP10.47%16,390,000$132.76MInstitution
Vanguard Group Inc10.24%16,033,545$129.87MInstitution
State Street Corp7.37%11,532,088$93.41MInstitution
Bryan E. Roberts6.90%10,800,857$87.49MInsider
Fmr LLC5.85%9,153,685$74.14MInsider
Associates Venrock5.58%8,733,763$70.74MInsider
Ridgeback Capital Investments LP4.37%6,842,839$55.43MInsider
Lsv Asset Management4.33%6,782,101$54.94MInstitution

1 of 3

IRWD vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IRWD72.14%27.86%Net SellingNet Selling
PCRX68.56%31.44%Net SellingNet Selling
TLRY8.97%1.99%Net Buying
ANIP21.94%78.06%Net SellingNet Selling
DCPH67.07%32.93%Net BuyingNet Buying

Ironwood Pharmaceuticals Stock Ownership FAQ

Who owns Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals (NASDAQ: IRWD) is owned by 105.41% institutional shareholders, 40.70% Ironwood Pharmaceuticals insiders, and 0.00% retail investors. Alexander J. Denner is the largest individual Ironwood Pharmaceuticals shareholder, owning 16.51M shares representing 10.55% of the company. Alexander J. Denner's Ironwood Pharmaceuticals shares are currently valued at $133.42M.

If you're new to stock investing, here's how to buy Ironwood Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.